Patients Clinicians About Investor Center FIND A DOCTOR Press Releases Press Releases Quarterly Results Isoray Announces First Quarter Fiscal 2022 Financial Results November 10, 2021 Prostate Revenue Increased Year-Over-Year for Second Consecutive Quarter Non-Prostate Brachytherapy Revenue ... Isoray To Announce First Quarter Fiscal 2022 Financial Results on November 10, 2021 October 29, 2021 Conference Call is Wednesday, November 10, 2021 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, WASHINGTON –October 29, ... American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Isoray’s Cesium-131 September 28, 2021 RICHLAND, WASHINGTON – September 28, 2021 – The American Brachytherapy Society (ABS) has recognized Isoray’s ... Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues September 21, 2021 Conference Call Rescheduled for Wednesday, September 22 at 10:00 a.m. ET/7:00 a.m. PT RICHLAND, ... Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results September 21, 2021 Record Full Year Revenue Fiscal Fourth Quarter Revenue Increased 19% Year-Over-Year RICHLAND, WASHINGTON – ... Isoray To Announce Fourth Quarter and Fiscal Year End 2021 Financial Results on September 21, 2021 September 9, 2021 Conference Call is Tuesday, September 21 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, WASHINGTON – September 9, 2021 – ... Isoray Announces Third Quarter Fiscal 2021 Financial Results May 13, 2021 Revenue Increased 10% Sequentially Record Non-Prostate Brachytherapy Revenue Increased 20% ... Isoray To Announce Third Quarter Fiscal 2021 Financial Results on May 13, 2021 April 29, 2021 Conference Call is Thursday, May 13 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, WASHINGTON – April 29, 2021 – Isoray, ... Isoray Announces the Appointment of Donna Fort as Vice President Sales and Marketing April 13, 2021 RICHLAND, WASHINGTON – April 13, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed ... University Hospitals Cleveland Medical Center Pilot Study Shows Promise for High-Risk Recurrent Head and Neck Cancer Treatment with Cesium-131 and Surgical Resection March 31, 2021 RICHLAND, WASHINGTON – March 31, 2021 – A recently published small prospective series of patients with recurrent ... Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference March 3, 2021 RICHLAND, WASHINGTON – March 3, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed ... Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development February 16, 2021 RICHLAND, WASHINGTON – February 16, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed 1 2 3 5 Proven • Personalized • Precise Patients & Families Cesium Blu Prostate Cancer Treatment Areas Together Community Doctors & Clinicians Cesium Blu The Data Contact Us Our Products Our company About Us Careers Contact Us Connect with us: Copyright © 2021 Isoray Inc. Terms of Use Privacy Policy Disclosure: The physicians featured on this website may have prior or current relationships with Isoray. These relationships may include, for example: membership on Isoray’s Advisory Board; participation as a clinical investigator in research conducted on Isoray products; provision of consultation or training services; or engagement as a prospective partner in the development of new products. Many of these physicians have received or continue to receive compensation from Isoray in one form or another. The principal nature of a specific physician’s relationship is disclosed on this website adjacent to language featuring that physician. Which of these best describes you? I'm a patient or family member living with cancer. I'm a clinician or doctor. I'm an investor. Other Powered byRightMessage ✕